Jiahong Wang. (2023). Levetiracetam plus Oxcarbazepine Combination Treatment Downregulates Serum Multidrug Resistance Protein 1 Levels and Upregulates Neuropeptide Y Levels in Children with Epilepsy. Universidade de São Paulo.
Chicago Style (17th ed.) CitationJiahong Wang. Levetiracetam Plus Oxcarbazepine Combination Treatment Downregulates Serum Multidrug Resistance Protein 1 Levels and Upregulates Neuropeptide Y Levels in Children with Epilepsy. Universidade de São Paulo, 2023.
MLA (9th ed.) CitationJiahong Wang. Levetiracetam Plus Oxcarbazepine Combination Treatment Downregulates Serum Multidrug Resistance Protein 1 Levels and Upregulates Neuropeptide Y Levels in Children with Epilepsy. Universidade de São Paulo, 2023.
Warning: These citations may not always be 100% accurate.